These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36284689)

  • 1. Development and Application of a Multidrug-Resistant Tuberculosis Case Management System - Yunnan Province, China, 2017-2020.
    Chen J; Ruan Y; Wang K; Li L; Yang Y; Yang R; Xu L
    China CDC Wkly; 2022 Sep; 4(38):855-861. PubMed ID: 36284689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
    Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
    BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study.
    Zheng XB; Diwan VK; Zhao Q; Hu Y; Bruchfeld J; Jiang WL; Hoffner S; Xu B
    Infect Dis Poverty; 2020 Jul; 9(1):97. PubMed ID: 32682446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
    Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
    BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The long term (9-year) survival of multidrug-resistant tuberculosis patients compared to non-multidrug-resistant tuberculosis patients in Henan province].
    Sun YN; Wang GJ; Zhen XA; Liu ZF; Harley D; Hall G; Vally H; Sleigh A
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):133-6. PubMed ID: 23751466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proportions and Risk Factors of Developing Multidrug Resistance Among Patients with Tuberculosis in China: A Population-Based Case-Control Study.
    Huai P; Huang X; Cheng J; Zhang C; Wang K; Wang X; Yang L; Deng Z; Ma W
    Microb Drug Resist; 2016 Dec; 22(8):717-726. PubMed ID: 27058017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Loss to follow-up in patients treated for multidrug-resistant tuberculosis in EcuadorA Perda de seguimento de pacientes tratados para tuberculose multirresistente a medicamentos no Equador].
    Tatés-Ortega N; Álvarez J; López L; Mendoza-Ticona A; Alarcón-Arrascue E
    Rev Panam Salud Publica; 2019; 43():e91. PubMed ID: 31892925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study.
    Chen S; Huai P; Wang X; Zhong J; Wang X; Wang K; Wang L; Jiang S; Li J; Peng Y; Ma W
    Int J Infect Dis; 2013 Dec; 17(12):e1116-20. PubMed ID: 23916547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining
    Yao S; Yan J; Li L; Ma D; Liu J; Wang Q; Wang A; Bao F; Zhang Z; Bao X
    Infect Drug Resist; 2020; 13():1023-1032. PubMed ID: 32308444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study.
    Elduma AH; Mansournia MA; Foroushani AR; Ali HMH; Elegail AMA; Elsony A; Holakouie-Naieni K
    Epidemiol Health; 2019; 41():e2019014. PubMed ID: 31010280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.
    He XC; Zhang XX; Zhao JN; Liu Y; Yu CB; Yang GR; Li HC
    Medicine (Baltimore); 2016 Apr; 95(15):e3336. PubMed ID: 27082586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China.
    Liu Z; Zhang M; Wang J; Chen S; Wu B; Zhou L; Pan A; Wang W; Wang X
    Biomed Res Int; 2020; 2020():3159482. PubMed ID: 32104686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Multidrug-Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling.
    Liu YX; Pang CK; Liu Y; Sun XB; Li XX; Jiang SW; Xue F
    PLoS One; 2015; 10(5):e0128298. PubMed ID: 26020921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trend prediction and spatial-temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014-2020.
    Yun W; Huijuan C; Long L; Xiaolong L; Aihua Z
    BMC Infect Dis; 2022 Jun; 22(1):525. PubMed ID: 35672746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
    Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
    BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant tuberculosis in Zhejiang Province, China: an updated analysis of time trends, 1999-2013.
    Wu B; Zhang L; Liu Z; He H; Pan A; Wang F; Zhang M; Chen B; Lu Z; Chen S; Wang X
    Glob Health Action; 2017; 10(1):1293925. PubMed ID: 28578621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009-2013.
    Peng Y; Chen SH; Zhang L; Chen B; Zhang MW; He TN; Wang F; Chai CL; Zhou L; Zhang Y; Wang XM; Jia Z
    Chin Med J (Engl); 2017 Sep; 130(17):2021-2026. PubMed ID: 28836544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.